Company Description
FOCALTHERICS (NASDAQ: FOCL) is a publicly traded medical distribution company in the Electromedical & Electrotherapeutic Apparatus sector. The company has a market capitalization of $180.3M, ranking #4,750 among all listed U.S. companies by market cap.
FOCL stock has gained 0.6% over the past year. Shares last traded at $4.81.
On a trailing twelve-month basis, FOCALTHERICS reported revenue of $70.5M with net income of -$29.2M and diluted earnings per share of $-0.78. The company operates at a net profit margin of -41.5%.
This page provides a comprehensive overview of FOCL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
FOCALTHERICS (FOCL) stock last traded at $4.81. Over the past 12 months, the stock has gained 0.6%. At a market capitalization of $180.3M, FOCL is classified as a micro-cap stock with approximately 37.5M shares outstanding.
FOCL Rankings
Latest News
FOCALTHERICS has 1 recent news article, with the latest published 5 days ago. View all FOCL news →
SEC Filings
Financial Highlights
FOCALTHERICS generated $70.5M in revenue over the trailing twelve months, retaining a 42.5% gross margin, operating income reached -$24.7M (-35.0% operating margin), and net income was -$29.2M, reflecting a -41.5% net profit margin. Diluted earnings per share stood at $-0.78. The company generated -$16.4M in operating cash flow. With a current ratio of 1.54, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
FOCL Company Profile & Sector Positioning
FOCALTHERICS (FOCL) operates in the Medical Distribution industry within the broader Electromedical & Electrotherapeutic Apparatus sector and is listed on the NASDAQ. In monthly performance, the stock ranks #1,989 among all tracked companies.